Celldex Therapeutics (CLDX)
2.34
+0.02 +0.86%
NASDAQ
Aug 23, 13:07
Delayed 2m
USD
View All Key Stats
CLDX Key Stats
| Income Statement | |
| Revenue (TTM) | 9.456M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.10 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -124.73M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -746.0% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 300.32M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 28.24 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.298 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -21.73M |
| Return on Equity (TTM) | -52.12% |
View All CLDX News
CLDX News
-
WireHeadlineTime (ET)
-
MT Newswires08/23 09:38
-
Globe Newswire08/23 09:15
-
Yahoo08/19 12:03
-
Yahoo08/16 20:15
-
Yahoo08/14 09:37
-
Yahoo08/14 08:26
-
Yahoo08/14 02:11
-
Yahoo08/09 10:48
-
Yahoo08/09 08:02
-
Yahoo08/08 23:55
View All Events
CLDX Events
| Date | Type | Description |
|---|---|---|
| 08/08/2017 16:30 EDT | Earnings | Celldex Therapeutics Inc Second Quarter Earnings Results in 2017 |
| 06/15/2017 | Misc | Celldex Therapeutics Inc Annual General Meeting in 2016 |
| 05/09/2017 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results in 2017 |
| 03/14/2017 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2016 |
| 03/14/2017 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2016 Release |
| 11/29/2016 | Misc | Celldex Therapeutics Completes Acquisition of Kolltan Pharmaceuticals |
| 11/07/2016 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results in 2016 |
| 11/01/2016 | Misc | Celldex Expands Antibody and Immuno-oncology Portfolio With the Acquisition of Kolltan Pharmaceuticals |
CLDX Fundamentals
Income Statement View Statement
CLDX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
CLDX One Page Reports
- One Page Report Download
CLDX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 2.34 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 08, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
CLDX Comparables
EditCLDX Excel Add-In Codes
- Name: =YCI("CLDX","name")
- Description: =YCI("CLDX","description")
- Sector: =YCI("CLDX","sector")
- Industry: =YCI("CLDX","industry")
- Est. Current Fiscal Year End: =YCI("CLDX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other CLDX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
